Zhejiang Garden Biopharmaceutical Co.,Ltd.’s Net Profit Dropped 60.5% in First Half of 2023

Zhejiang Garden Biopharmaceutical Co.,Ltd. (浙江花园生物医药股份有限公司) (300401.SZ) reported a net profit of 117.2 million yuan in the first half of 2023, down 60.5% year-on-year.

Meanwhile, the company posted 656.7 million yuan in revenue, down 18% year-on-year.

At the end of the reporting period, it had 5.6 billion yuan in total assets and 2.7 billion yuan in total liabilities, with a liability-to-asset ratio of 47.6%.